Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Cell Biochem Biophys. 2024 Mar;82(1):77-90. doi: 10.1007/s12013-023-01156-x. Epub 2023 Oct 17.
Prostate cancer (PCa) is a common malignant tumor in men, when the disease progresses to the advanced stage, most patients will develop distant metastasis and develop into castration-resistant prostate cancer (CRPC), resulting in increased mortality. Ubiquitination is a widespread protein post-translational modification process in the biological world, and it plays an important role in the development and transfer of PCa. E3 ubiquitin ligase plays an important role in the specific selection and role of substrates in the process of ubiquitination ligase. This review will briefly introduce the ubiquitination process and E3 ubiquitin ligase, focus on the recently discovered multiple mechanisms by which ubiquitination affects PCa development and metastasis, and a summary of the current emerging proteolysis-targeting chimeras (PROTAC) in the treatment of PCa.
前列腺癌(PCa)是男性常见的恶性肿瘤,当疾病进展到晚期时,大多数患者会发生远处转移并发展为去势抵抗性前列腺癌(CRPC),导致死亡率增加。泛素化是生物界中广泛存在的一种蛋白质翻译后修饰过程,在 PCa 的发生和转移中发挥着重要作用。E3 泛素连接酶在泛素连接酶的过程中对底物的特异性选择和作用起着重要作用。本文将简要介绍泛素化过程和 E3 泛素连接酶,重点介绍最近发现的泛素化影响 PCa 发展和转移的多种机制,并总结目前用于治疗 PCa 的新兴蛋白水解靶向嵌合体(PROTAC)。